The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...

Uterine carcinosarcoma, also referred to as malignant mixed Müllerian tumor, is a rare and highly aggressive neoplasm ...

Cervical cancer was once the most common cancer in females but liver cancer is catching up and could soon be the second most ...

You’ve probably heard of the four stages of cancer—but there’s another even earlier stage that experts say can make a huge ...